In conclusion, our study has confirmed that Brevilin A impedes prostate cancer cell proliferation, migration, and invasion and exerts its anti-tumor function in prostate cancer through modulating the lncRNA H19/miR-194/E2F3 signaling pathway. This evidence concerns the gene E2F3 and prostate cancer.